Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues
BackgroundNeoadjuvant immunotherapy (NIT) is a rapidly emerging paradigm for advanced resectable non-small cell lung cancer (NSCLC). However, there is no bibliometric analysis in this research field.ObjectiveTo analyze the hotspots and trends in the research of NIT for NSCLC and provide a reference...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1533651/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860970294870016 |
|---|---|
| author | Pengliang Xu Huanming Yu Hupo Bian Dan Jia Wenhui Li Hongfeng Dong Xiuhua Peng |
| author_facet | Pengliang Xu Huanming Yu Hupo Bian Dan Jia Wenhui Li Hongfeng Dong Xiuhua Peng |
| author_sort | Pengliang Xu |
| collection | DOAJ |
| description | BackgroundNeoadjuvant immunotherapy (NIT) is a rapidly emerging paradigm for advanced resectable non-small cell lung cancer (NSCLC). However, there is no bibliometric analysis in this research field.ObjectiveTo analyze the hotspots and trends in the research of NIT for NSCLC and provide a reference for the study of NIT for lung cancer in China.MethodsRetrieve literature related to NIT for NSCLC from Web of Science, PubMed, and Scopus databases up to September 10, 2024. Use CiteSpace and VOSviewer software visualization software to analyze the keywords of country, author, institution, and literature.ResultsThere were 1575 references, and the overall annual publication volume showed an upward trend; Forde and Patrick M have published the most articles in the literature. The research hotspots mainly focus on chemotherapy, NIT for NSCLC, immunotherapy, neoadjuvant chemotherapy, pathological reactions, etc.ConclusionsThis is the first bibliometric study comprehensively summarizing NIT’s research trends and development in NSCLC. Our bibliometric assessment provides a panoramic view of the research milieu surrounding NIT for NSCLC, encapsulating the present state, evolving trends, and potential future directions, particularly emphasizing the promise of immunochemotherapy. |
| format | Article |
| id | doaj-art-84c41f6946c64b2fac539a2b60b1abc4 |
| institution | Kabale University |
| issn | 1664-3224 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Immunology |
| spelling | doaj-art-84c41f6946c64b2fac539a2b60b1abc42025-02-10T06:48:47ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-02-011610.3389/fimmu.2025.15336511533651Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenuesPengliang Xu0Huanming Yu1Hupo Bian2Dan Jia3Wenhui Li4Hongfeng Dong5Xiuhua Peng6Department of Thoracic Surgery, The First People’s Hospital of Huzhou, Huzhou, ChinaDepartment of Thoracic Surgery, The First People’s Hospital of Huzhou, Huzhou, ChinaDepartment of Radiology, The First People’s Hospital of Huzhou, Huzhou, ChinaDepartment of Respiratory Medicine, The First People’s Hospital of Huzhou, Huzhou, ChinaDepartment of Thoracic Surgery, The First People’s Hospital of Huzhou, Huzhou, ChinaDepartment of Radiology, The First People’s Hospital of Huzhou, Huzhou, ChinaDepartment of Radiology, The First People’s Hospital of Huzhou, Huzhou, ChinaBackgroundNeoadjuvant immunotherapy (NIT) is a rapidly emerging paradigm for advanced resectable non-small cell lung cancer (NSCLC). However, there is no bibliometric analysis in this research field.ObjectiveTo analyze the hotspots and trends in the research of NIT for NSCLC and provide a reference for the study of NIT for lung cancer in China.MethodsRetrieve literature related to NIT for NSCLC from Web of Science, PubMed, and Scopus databases up to September 10, 2024. Use CiteSpace and VOSviewer software visualization software to analyze the keywords of country, author, institution, and literature.ResultsThere were 1575 references, and the overall annual publication volume showed an upward trend; Forde and Patrick M have published the most articles in the literature. The research hotspots mainly focus on chemotherapy, NIT for NSCLC, immunotherapy, neoadjuvant chemotherapy, pathological reactions, etc.ConclusionsThis is the first bibliometric study comprehensively summarizing NIT’s research trends and development in NSCLC. Our bibliometric assessment provides a panoramic view of the research milieu surrounding NIT for NSCLC, encapsulating the present state, evolving trends, and potential future directions, particularly emphasizing the promise of immunochemotherapy.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1533651/fullnon-small cell lung cancerneoadjuvant immunotherapychemotherapyCiteSpacevisual analysis |
| spellingShingle | Pengliang Xu Huanming Yu Hupo Bian Dan Jia Wenhui Li Hongfeng Dong Xiuhua Peng Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues Frontiers in Immunology non-small cell lung cancer neoadjuvant immunotherapy chemotherapy CiteSpace visual analysis |
| title | Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues |
| title_full | Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues |
| title_fullStr | Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues |
| title_full_unstemmed | Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues |
| title_short | Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues |
| title_sort | bibliometric insight into neoadjuvant immunotherapy in non small cell lung cancer trends collaborations and future avenues |
| topic | non-small cell lung cancer neoadjuvant immunotherapy chemotherapy CiteSpace visual analysis |
| url | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1533651/full |
| work_keys_str_mv | AT pengliangxu bibliometricinsightintoneoadjuvantimmunotherapyinnonsmallcelllungcancertrendscollaborationsandfutureavenues AT huanmingyu bibliometricinsightintoneoadjuvantimmunotherapyinnonsmallcelllungcancertrendscollaborationsandfutureavenues AT hupobian bibliometricinsightintoneoadjuvantimmunotherapyinnonsmallcelllungcancertrendscollaborationsandfutureavenues AT danjia bibliometricinsightintoneoadjuvantimmunotherapyinnonsmallcelllungcancertrendscollaborationsandfutureavenues AT wenhuili bibliometricinsightintoneoadjuvantimmunotherapyinnonsmallcelllungcancertrendscollaborationsandfutureavenues AT hongfengdong bibliometricinsightintoneoadjuvantimmunotherapyinnonsmallcelllungcancertrendscollaborationsandfutureavenues AT xiuhuapeng bibliometricinsightintoneoadjuvantimmunotherapyinnonsmallcelllungcancertrendscollaborationsandfutureavenues |